Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Synaptogenix, Inc. (SNPX) had Stock-Based Compensation of $1.13M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-1.23M |
|
-- |
|
-- |
|
$2.13M |
|
$-2.13M |
|
$1.14M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
$-2.13M |
|
$-2.13M |
|
0.47M |
|
0.47M |
|
$12.50 |
|
$12.50 |
|
| Balance Sheet Financials | |
$30.53M |
|
$0.02M |
|
$0.58M |
|
$31.11M |
|
$4.28M |
|
-- |
|
$1.25M |
|
$5.53M |
|
$24.35M |
|
$25.58M |
|
$25.58M |
|
0.96M |
|
| Cash Flow Statement Financials | |
$-5.17M |
|
$-2.00M |
|
$-1.64M |
|
$37.48M |
|
$28.66M |
|
$-8.82M |
|
|
Stock-Based Compensation |
$1.13M |
-- |
|
$-0.64M |
|
| Fundamental Metrics & Ratios | |
7.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.09% |
|
-3.89% |
|
-3.20% |
|
-3.89% |
|
$26.55 |
|
$-11.11 |
|
$-11.10 |
|